BioLineRx (BLRX) Current Leases (2019 - 2025)
BioLineRx's (BLRX) quarterly Current Leases came in at $977000.0 in Q4 2025, down 9.62% year-on-year from $1.1 million in Q4 2024, and down 2.59% quarter-over-quarter from $1.0 million in Q3 2025.
BioLineRx (BLRX) Current Leases (2019 - 2025) Analysis & Trends
BioLineRx's Current Leases history runs 7 years deep, the most recent figure standing at $977000.0 for Q4 2025.
- On a quarterly basis, Current Leases fell 9.62% year-over-year to $977000.0 in Q4 2025; TTM through Dec 2025 was $977000.0, a 9.62% decrease from a year earlier, with the FY2025 full-year figure at $977000.0, down 9.62% from the prior year.
- Current Leases retreated to $977000.0 in Q4 2025 per BLRX's latest filing, from $1.0 million in the prior quarter.
- Across five years, Current Leases topped out at $1.7 million in Q4 2022 and bottomed at $977000.0 in Q4 2025.
- The 5-year median for Current Leases is $1.4 million (2022), against an average of $1.4 million.
- Across the five-year window, Current Leases rose 9.44% in 2023 and dropped 27.79% in 2024, its largest moves.
- Year by year, Current Leases stood at $1.7 million in 2021, then grew by 0.17% to $1.7 million in 2022, then declined by 25.39% to $1.3 million in 2023, then decreased by 16.2% to $1.1 million in 2024, then slipped by 9.62% to $977000.0 in 2025.
- Per Business Quant, the three latest BLRX Current Leases figures stand at $977000.0 (Q4 2025), $1.0 million (Q3 2025), and $998000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | 977,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 977,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 998,000.00 |
| Mar 31, 2025 | 985,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | 1.73 Mn |
| Sep 30, 2022 | 1.51 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.66 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 1.68 Mn |
| Jun 30, 2021 | 1.70 Mn |
| Mar 31, 2021 | 1.60 Mn |